Betta Pharmaceuticals Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022
Market Capitalization	20,835	19,644	22,569	21,573	20,525	33,154
Market Cap Growth	-2.82%	-12.96%	4.62%	5.11%	-38.09%	-25.26%
Enterprise Value	22,953	21,688	24,170	23,045	20,899	31,905
Last Close Price	49.52	46.69	53.76	51.15	48.82	78.66
PE Ratio	47.07	64.34	56.06	61.99	141.14	86.55
Forward PE	26.48	26.59	29.63	42.25	65.91	49.20
PS Ratio	5.58	5.44	7.80	8.78	8.64	14.76
PB Ratio	3.04	2.95	3.98	4.03	4.14	7.08
P/TBV Ratio	5.74	5.49	9.47	7.45	6.38	11.18
P/FCF Ratio	205.13	66.69	270.04	-	-	-
P/OCF Ratio	23.75	21.56	24.77	23.60	66.91	62.96
PEG Ratio	-	3.08	3.08	3.08	3.08	3.08
EV/Sales Ratio	6.15	6.01	8.36	9.38	8.79	14.21
EV/EBITDA Ratio	18.99	19.93	28.60	39.86	46.08	61.61
EV/EBIT Ratio	37.43	40.13	50.68	82.34	100.98	91.48
EV/FCF Ratio	225.99	73.62	289.20	-	-	-
Debt / Equity Ratio	0.37	0.37	0.42	0.45	0.21	0.00
Debt / EBITDA Ratio	2.12	2.26	2.82	4.17	2.27	0.02
Debt / FCF Ratio	25.22	8.36	28.67	-	-	-
Net Debt / Equity Ratio	0.30	0.30	0.32	0.31	0.06	-0.21
Net Debt / EBITDA Ratio	1.70	1.81	2.13	2.90	0.70	-1.90
Net Debt / FCF Ratio	20.19	6.68	21.51	-9.23	-0.45	4.24
Asset Turnover	0.38	0.36	0.31	0.29	0.34	0.39
Inventory Turnover	2.40	2.20	1.74	1.16	0.81	0.72
Quick Ratio	0.62	0.48	0.38	0.58	0.59	1.36
Current Ratio	0.99	0.82	0.66	0.85	0.82	1.86
Return on Equity (ROE)	6.75%	4.64%	7.03%	6.47%	2.59%	8.60%
Return on Assets (ROA)	3.87%	3.39%	3.23%	2.05%	1.82%	3.79%
Return on Invested Capital (ROIC)	5.14%	4.64%	6.46%	4.55%	4.61%	10.75%
Return on Capital Employed (ROCE)	6.80%	6.20%	6.40%	3.80%	3.60%	6.50%
Earnings Yield	2.12%	1.55%	1.78%	1.61%	0.71%	1.16%
FCF Yield	0.49%	1.50%	0.37%	-0.84%	-3.43%	-0.70%
Dividend Yield	0.30%	0.32%	0.37%	0.33%	0.14%	0.32%
Payout Ratio	33.40%	49.38%	37.48%	31.69%	95.94%	35.93%
Buyback Yield / Dilution	-0.57%	0.26%	-0.01%	-0.72%	0.02%	-2.32%
Total Shareholder Return	-0.27%	0.58%	0.37%	-0.39%	0.16%	-2.00%

Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.